Amryt Pharma Plc (AMYT) ORD GBP0.06
3.00p
(1.72%)
- Add to watchlist
- Create an alert
- This stock can be held in a
3.00p
(1.72%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
3.00p
(1.72%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
174.00p
175.00p
228.00p
£541.91 million
174.00p
168.00p
148.00p
n/a
3.00p (1.69%) Previous:
3.00p
37,998
n/a
1,500
Performance
| 1 week 1W | 2.52% | 1 year 1Y | 12.12% |
|---|---|---|---|
| 1 month 1M | 3.33% | 2 years 2Y | 49.36% |
| 3 months 3M | 2.96% | 3 years 3Y | 1079.66% |
| 6 months 6M | 14.07% | 5 years 5Y | 970.77% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2020 | 31/12/2019 |
|---|---|---|
| Revenue ($m) | 182.61 | 58.12 |
| Profit before tax ($m) | (105.86) | (63.49) |
| Adjusted EPS (¢): | (66.00) | (83.00) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.
Ready to invest?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
There are no documents available for this stock.
Broker forecasts
Due to changes in how we source investment data, Broker Forecasts are not available. We're sorry for any inconvenience this may cause.
-
Amryt Pharma granted another two US patents
19 October 2021 15:54
-
Record second quarter sees Amryt lift guidance further
6 August 2021 12:02
-
Cathal Friel-led Poolbeg Pharma set to float on AIM
17 June 2021 14:34
-
Amryt to Report Q3 2021 Results and Host Conference Call & Webcast on November 3
20 October 2021 12:00
-
Amryt Announces New Patents for Oleogel-S10 and Mycapssa®
19 October 2021 12:00
-
Amryt Raises Full Year 2021 Revenue Guidance to $220M - $225M
13 September 2021 12:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Annual & interim reports
Annual & interim reports are not available for this stock.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.